Project: FRIDASTEM: A novel drug discovery platform delivering breakthrough cancer stem cell (CSC) drugs

FRIDASTEM aims at building a novel platform for screening fragments and small molecule libraries against unexplored CSC-specific GPCRs and kinases involved in CSC proliferation, migration and invasion. The platform will be offered for screening services after validation: by using known inhibitors and by identifying new molecular entities (NME) with anticancer properties. Selected hits will be optimized towards early leads. At least one lead will be chosen to for further preclinical development.

Acronym FRIDASTEM (Reference Number: 9723)
Duration 01/10/2015 - 01/10/2018
Project Topic Biological Sciences / Technologies
Network Eurostars 2
Call Eurostars Cut-Off 3

Project partner

Number Name Role Country
21445 Canvax Biotech Coordinator Spain
21446 Villapharma Research Partner Spain
21447 Proteros biostructures GmbH Partner Germany